Archivserver der Deutschen Nationalbibliothek

51. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK,
Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Pocock SJ,
Kuntz RE. A clinical trial comparing three antithrombotic-drug
regimens after coronary-artery stenting. Stent Anticoagulation
Restenosis Study Investigators. N Engl J Med. 1998; 339:1665-71.
52. Hardhammar PA, van Beusekom HM, Emanuelsson HU, Hofma SH,
Albertsson PA, Verdouw PD, Boersma E, Serruys PW, van der Giessen
WJ. Reduction in thrombotic events with heparin-coated Palmaz-Schatz
stents in normal porcine coronary arteries. Circulation. 1996; 93:423-30.
53. Serruys PW, van Hout B, Bonnier H, Legrand V, Garcia E, Macaya C,
Sousa E, van der Giessen W, Colombo A, Seabra-Gomes R, Kiemeneij F,
Ruygrok P, Ormiston J, Emanuelsson H, Fajadet J, Haude M, Klugmann
S, Morel MA. Randomised comparison of implantation of heparincoated
stents with balloon angioplasty in selected patients with coronary
artery disease (Benestent II). Lancet. 1998; 352:673-81.
54. Leon MB. Late thrombosis a concern with drug-eluting stents. J Interv
Cardiol. 2007; 20:26-9.
55. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M,
Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R.
A randomized comparison of a sirolimus-eluting stent with a standard
stent for coronary revascularization. N Engl J Med. 2002; 346:1773-80.
56. Sousa JE CM, Sousa AG, Abizaid AC, Seixas AC, Abizaid AS, Feres F,
Mattos LA, Falotico R, Jaeger J, Popma JJ, Serruys PW. Two-year
angiographic and intravascular ultrasound follow-up after implantation
of sirolimus-eluting stents in human coronary arteries. Circulation.
2003; 107:381-383.
57. Kim YH, Park SW, Lee CW, Hong MK, Gwon HC, Jang Y, Lee MM, Koo
BK, Oh DJ, Seung KB, Tahk SJ, Yoon J, Park SJ. Comparison of
sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in
the treatment of long coronary lesions. Catheter Cardiovasc Interv.
2006; 67:181-7.
66